Columbia Laboratories, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 29,226 25,828 43,062 45,676
Cost of Revenue 13,251 12,788 11,691 9,021
Gross Profit 15,976 13,040 31,371 36,655
Operating Expenses
Research and Development - 771 2,779 8,582
Sales, General and Admin. 8,477 9,460 8,196 24,377
Non-Recurring Items 1,623 - - -
Other - - - 2,522
Operating Income 5,875 2,810 22,929 1,174
Income From Continuing Operations
Add'l Income/Expense Items 851 7,110 171 (18,642)
Earnings Before Interest and Tax 6,726 9,920 20,566 (17,468)
Interest Expense - - - 4,838
Earnings Before Tax 6,726 9,920 20,566 (22,306)
Income Tax 23 3 39 (475)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 6,704 9,917 20,527 (26,987)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 6,704 9,917 20,527 (21,831)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 6,704 9,917 20,527 (21,831)